Immunophenotypic Features of Granulocytes, Monocytes, and Blasts in Myelodysplastic Syndromes
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Despite the diagnostic utility of immunophenotyping for myelodysplastic syndromes (MDS), it has not been widely performed, and reports on this are absent in Korea. We aimed to evaluate the immunophenotypic features of non-blastic granulocytes, monocytes, and blasts in patients with MDS and non-clonal disorders using routine flow cytometry (FCM). Moreover, we evaluated the phenotypic abnormalities of mature cells in leukemic patients. Methods: Marrow aspirates from 60 patients, including 18 with MDS, 18 with leukemia, and 24 with non-clonal disorders (control group), were analyzed using FCM. Blasts, non-blast myeloid cells, and monocytes were gated based on CD45 expression and side scatter (SSC). The phenotypes were then compared among the 3 groups. Results: Compared to non-clonal disorders, the granulocytic lineages of MDS showed decreased SSC (P=0.005), increased CD45 intensity (P=0.020), decreased CD10-positive granulocytes (P=0.030), and a higher CD56-positive rate (P=0.005). It is noteworthy that similar results were obtained in the leukemia group, and these findings were not related to the phenotypes of the leukemic cells. Using blast and monocytic gating, useful parameters for generating a differential diagnosis were not found. Conclusions: Gating the granulocytic region is a relatively easy method for MDS immunophenotyping. Among the parameters studied, SSC, CD10, and CD56 were the most useful for differentiating MDS from non-clonal disorders. While immunophenotypic changes in MDS appear to be useful for differentiating MDS from non-clonal disorders, these changes were also noted in the mature cells of leukemic patients. (Korean J Lab Med 2010;30:97-104)
Abstract
Background: Despite the diagnostic utility of immunophenotyping for myelodysplastic syndromes (MDS), it has not been widely performed, and reports on this are absent in Korea. We aimed to evaluate the immunophenotypic features of non-blastic granulocytes, monocytes, and blasts in patients with MDS and non-clonal disorders using routine flow cytometry (FCM). Moreover, we evaluated the phenotypic abnormalities of mature cells in leukemic patients. Methods: Marrow aspirates from 60 patients, including 18 with MDS, 18 with leukemia, and 24 with non-clonal disorders (control group), were analyzed using FCM. Blasts, non-blast myeloid cells, and monocytes were gated based on CD45 expression and side scatter (SSC). The phenotypes were then compared among the 3 groups. Results: Compared to non-clonal disorders, the granulocytic lineages of MDS showed decreased SSC (P=0.005), increased CD45 intensity (P=0.020), decreased CD10-positive granulocytes (P=0.030), and a higher CD56-positive rate (P=0.005). It is noteworthy that similar results were obtained in the leukemia group, and these findings were not related to the phenotypes of the leukemic cells. Using blast and monocytic gating, useful parameters for generating a differential diagnosis were not found. Conclusions: Gating the granulocytic region is a relatively easy method for MDS immunophenotyping. Among the parameters studied, SSC, CD10, and CD56 were the most useful for differentiating MDS from non-clonal disorders. While immunophenotypic changes in MDS appear to be useful for differentiating MDS from non-clonal disorders, these changes were also noted in the mature cells of leukemic patients. (Korean J Lab Med 2010;30:97-104)
참고문헌 (26)
- Kussick SJ, "Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia", Am J Clin Pathol, 124, pp.170~181 (2005)
- Ogata K, "Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes", Blood, 108, pp.1037~1044 (2006)
- Ogata K, "Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome", Blood, 100, pp.3887~3896 (2002)
- Xu D, "Evidence for expression of early myeloid antigens in mature, nonblast myeloid cells in myelodysplasia", Am J Hematol, 74, pp.9~16 (2003)
- Wells DA, "Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation", Blood, 102, pp.394~403 (2003)
- Stetler-Stevenson M, "Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome", Blood, 98, pp.979~987 (2001)
- Wood BL, "Flow cytometric diagnosis of myelodysplasia and myeloproliferative disorders", J Biol Regul Homeost Agents, 18, pp.141~145 (2004)
- Swerdlow SH, "WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed" (2008), IARC Press
- Casasnovas RO, "Immunological classification of acute myeloblastic leukemias:relevance to patient outcome", Leukemia, 17, pp.515~527 (2003)
- Elghetany MT, "Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome", Blood, 99, pp.391~392 (2002)
- Chang CC, "Decreased CD10-positive mature granulocytes in bone marrow from patients with myelodysplastic syndrome", Arch Pathol Lab Med, 124, pp.1152~1156 (2000)
- Cherian S, "Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes", Cytometry B Clin Cytom, 64, pp.9~17 (2005)
- Del Canizo MC, "Vidriales B, Villaron E, Arroyo JL, et al. Immunophenotypic analysis of myelodysplastic syndromes", Haematologica, 88, pp.402~407 (2003)
- Orfao A, "Immunophenotyping of acute leukemias and myelodysplastic syndromes", Cytometry A, 58, pp.62~71 (2004)
- Ribeiro E, "Maturation-associated immunophenotypic abnormalities in bone marrow B-lymphocytes in myelodysplastic synd", Leuk Res, 30, pp.9~16 (2006)
- Kussick SJ, "Using 4-color flow cytometry to identify abnormal myeloid populations", Arch Pathol Lab Med, 127, pp.1140~1147 (2003)
- Cermak J, "The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia", Leuk Res, 29, pp.371~379 (2005)
- Dunphy CH, "Relative contributions of enzyme cytochemistry and flow cytometric immunophenotyping to the evaluation of acute myeloid leukemias with a monocytic component and of flow cytometric immunophenotyping to the evaluation of absolute monocytoses", Am J Clin Pathol, 122, pp.865~874 (2004)
- Lorand-Metze I, "Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders", Leuk Res, 31, pp.147~155 (2007)
- Pirruccello SJ, "Myeloblast phenotypic changes in myelodysplasia. CD34 and CD117 expression abnormalities are common", Am J Clin Pathol, 125, pp.884~894 (2006)
- Terstappen LW, "Flow cytometric analysis of human bone marrow. III. Neutrophil maturation", Leukemia, 4, pp.657~663 (1990)
- Mann KP, "Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes", Am J Clin Pathol, 107, pp.653~660 (1997)
- Schlesinger M, "Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome", J Clin Lab Immunol, 48, pp.149~166 (1996)
- Malcovati L, "Travaglino E, et al. Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome", Leukemia, 19, pp.776~783 (2005)
- Loken MR, "van de Loosdrecht A, Ogata K, Orfao A, Wells DA. Flow cytometry in myelodysplastic syndromes: report from a working conference", Leuk Res, 32, pp.5~17 (2008)
- Connelly JC, "Up-regulation of neutral endopeptidase (CALLA) in human neutrophils by granulocyte-macrophage colony-stimulating factor", J Leukoc Biol, 53, pp.685~690 (1993)